Results
Both groups had similar baseline characteristics distribution including
gender, race and age at temporary pacemaker insertion
(p>0.05). Subclavian vein was the most common site of
access for the TPPM cohort (89.0%) vs the femoral vein in the BTTP
group (65.1%). Ambulation was only possible in the TPPM group (55.6%,
p<0.001). Lead dislodgement, venous thromboembolism, local
hematoma, and access site infections were less frequently encountered in
the TPPM group (OR = 0.23 [95% CI (0.10-0.67), P<0.001]).
Within the subgroup of patients with TPPM, 36.6% of the patients were
monitored outside the ICU setting. There was no significant difference
in the pacemaker related adverse events among patients with TPPM based
on their in-hospital setting.